Cystatin C is a marker for acute kidney injury, but not for mortality among COVID-19 patients in Mexico

Cystatin C is a marker for acute kidney injury, but not for mortality among COVID-19 patients in Mexico

Background: Patients infected with SARS-CoV-2 can develop acute kidney injury (AKI), associated with adverse clinical outcomes. In Mexico, an AKI incidence of 60.7% was reported in patients with COVID-19. Serum cystatin C is a well-known marker for AKI. It has been postulated as a marker for mortali...

Full description

Bibliographic Details
Main Authors: Karime Ramos-Santos, Arturo Cortes-Telles, María Elena Uc-Miam, Azalia Avila-Nava, Roberto Lugo, Rodolfo Chim Aké, Ana Ligia Gutiérrez-Solis
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
COVID-19
Acute kidney injury
Cystatin C
Mexico
Mortality
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867022000538

Internet

http://www.sciencedirect.com/science/article/pii/S1413867022000538

Similar Items